CTT Pharmaceutical Holdings, Inc.
CTTH
$0.08
-$0.01-6.25%
OTC PK
| 03/31/2026 | 06/30/2015 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 107.59% | 13.49% | |||
| Depreciation & Amortization | -73.44% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 80.41% | 13.49% | |||
| Operating Income | -80.41% | -13.49% | |||
| Income Before Tax | -68.39% | -7.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -68.39% | -7.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -68.39% | -7.59% | |||
| EBIT | -80.41% | -13.49% | |||
| EBITDA | -83.69% | -- | |||
| EPS Basic | -55.56% | 1.73% | |||
| Normalized Basic EPS | -80.00% | 1.85% | |||
| EPS Diluted | -55.56% | 1.73% | |||
| Normalized Diluted EPS | -80.00% | 1.85% | |||
| Average Basic Shares Outstanding | 1.36% | 9.29% | |||
| Average Diluted Shares Outstanding | 1.36% | 9.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||